Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers
Brain and Behavior · 2025-05 · 15 (5)
DOI: 10.1002/brb3.70577 ↗At a glance
Journal article in Brain and Behavior, published online on 2025-05-26. Written by Yifei Zhao and 10 co-authors. Institution: Department of Neurology, Xianyang Hospital of Yan' an University, Xianyang, China. Major MEDLINE topics: Ischemic Stroke, Thrombosis. Cited 10 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Xianyang Hospital of Yan' an University.
Topics: Schlaganfall
Abstract (original language)
Background
Novel thrombotic molecular markers are significantly linked to acute ischemic stroke (AIS). However, the relationship between thrombin‐antithrombin complex (TAT), tissue plasminogen activator–inhibitor complex (t‐PAIC), plasmin‐α2 plasmin inhibitor complex (PIC), thrombomodulin (TM), and early neurological deterioration (END) remains unclear. Therefore, we developed a prediction model for END based on these markers and evaluated its accuracy and clinical utility.
Methods
Retrospective analysis of patients diagnosed with AIS in our hospital from 2023–2024. The above patients were divided into a training set (N = 577) and a test set (N = 246) in a 7:3 ratio. Least absolute shrinkage and selection of operator regression (LASSO) valid predictors were used. The coefficients of the predictors in logistic regression were used to develop a nomogram and to validate its differentiation, calibration, and clinical utility.
Results
The prevalence of END in AIS patients was 24.3%. Predictors screened according to LASSO regression analysis included age, the National Institutes of Health Stroke Scale (NIHSS) score, t‐PAIC, PIC, lymphocyte, and platelet. The resulting nomograms had the area under the curve (AUC) of 0.867 (95% CI, 0.834‐0.9) and 0.825 (95% CI, 0.757‐0.892) in the training and test sets, respectively, which had good differentiation. In addition, the calibration curve and decision curve analysis (DCA) showed that the model had good calibration and clinical utility.
Conclusion
A predictive model for END was developed using the serological markers t‐PAIC (male >17.13 ng/mL;female >10.52 ng/mL), PIC >0.85 µg/mL, Lymph ≤ 3.2×10^9/L, NIHSS, age, and platelet. The model has significant predictive value for END occurrence in patients with AIS.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Xianyang Hospital of Yan' an University, Xianyang, China.
- Department of Neurology, The First People's Hospital of Xianyang, Xianyang, China.
- Department of Neurological Intensive Care Unit, Xianyang Hospital of Yan'an University, Xianyang, China.
- Institute of Brain Disease, Xianyang Hospital of Yan'an University, Xianyang, China.
ORCID profiles: Ping Chen
Funding
- Xianyang Hospital of Yan' an University
Cite
APA
Zhao, Y., Zhu, H., Dai, C., Liu, W., Yu, W., Yan, B., Ji, X., Li, L., Wei, D., Li, Z., & Chen, P. (2025). Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers. Brain and Behavior, 15(5). https://doi.org/10.1002/brb3.70577
Vancouver
Zhao Y, Zhu H, Dai C, Liu W, Yu W, Yan B, et al. Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers. Brain and Behavior. 2025;15(5). doi:10.1002/brb3.70577
BibTeX
@article{Zhao2025,
author = {Zhao, Yifei and Zhu, Hao and Dai, Changfei and Liu, Wen and Yu, Wenjin and Yan, Bin and Ji, Xiyang and Li, Lin and Wei, Dong and Li, Zhaopan and Chen, Ping},
title = {Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {5},
doi = {10.1002/brb3.70577}
}
EUVIMED